BioMarin Pharmaceuticals BMRN United States — Total long-lived assets

Other geography segments

Similar metrics at other companies

IRENUnited States — Total long-lived assets

$1.63B+287%

FERGUnited States — Total long-lived assets

$1.89B—

ASANUnited States — Total long-lived assets

$201.6M-17.5%

ALH

ALHUnited States — Total long-lived assets

$192.71M+5.9%

TDYUnited States — Total long-lived assets

$527.3M-93.1%

PLCEUNITED STATES — Total long-lived assets

$308.95M+16.9%

FAQ

What is BioMarin Pharmaceuticals's united states — total long-lived assets?

BioMarin Pharmaceuticals (BMRN) reported united states — total long-lived assets of $639.67M in Q4 2025.

How has BioMarin Pharmaceuticals's united states — total long-lived assets changed year-over-year?

BioMarin Pharmaceuticals's united states — total long-lived assets decreased by 15.3% year-over-year, from $755.07M to $639.67M.

What does united states — total long-lived assets mean?

This metric represents the total carrying value of non-current, tangible, and intangible assets located within the United States. It includes property, plant, equipment, and capitalized R&D or intellectual property assets that support domestic operations and commercialization efforts. Monitoring this balance helps investors assess the geographic concentration of capital investment and the scale of physical infrastructure supporting the company's domestic market presence.